AuthorisedTherapeutic use (Phase IV)Interventional

IJAMP-Trial

The IJAMP-Trial is a research study focusing on a common problem: itching that can happen after a skin prick test. These tests are often used to check for allergies, but the itching afterward can be uncomfortable. This study is in its final stages of testing, known as Phase IV, which means the treatment being looked at has already been proven safe in earlier studies. Researchers are now observing how well it works and if it has any longer-term effects in a larger group of people. If you're an adult experiencing this kind of itch, this study might be looking for people like you to help find better ways to manage it.

At a glance

Status

Authorised

Phase

Therapeutic use (Phase IV)

Sponsor

Johannes Kepler University Linz

Enrolment target

Start

01 Jun 2026

prick test-induced itch

What is this study about?

The IJAMP-Trial is a study exploring new ways to treat a specific type of itch. This itch often occurs after you've had a skin prick test, which is a common procedure doctors use to see if you have allergies to things like pollen, dust mites, or certain foods. While these tests are important for diagnosing allergies, the little pricks on your skin can sometimes cause an itchy reaction that can be bothersome.

This study is in a stage called 'Phase IV'. This is an important step in developing new treatments. It means that the treatment or approach being studied has already been tested in earlier phases and found to be safe. Now, researchers want to see how well it works in a wider group of people when it's used in real-world situations. They are trying to find the best ways to use it to relieve this particular type of itching and understand if there are any long-term effects.

The main goal is to find better ways to help people who experience this specific itch after a skin prick test. By taking part, you could contribute to medical knowledge and potentially help future patients get relief from this uncomfortable symptom. The information gathered will help doctors make more informed decisions about treating itch related to allergy testing.

Key takeaways

The study is investigating treatments for itching after skin prick tests.
It's for adults aged 18 and over, of any sex.
The treatment has already been proven safe in earlier studies.
Participation could help find better ways to manage this specific itch.
You can withdraw from the study at any time.
Your medical information will be kept private.

Who may be eligible?

To be considered for this study, you need to be an adult, meaning you must be 18 years old or older. There is no upper age limit, so adults of any age can potentially take part.

This study is open to everyone, regardless of whether you are male or female. Researchers want to understand how the treatment works for all people who experience this type of itching.

The most important thing is that you experience itching specifically caused by a skin prick test. The study is focused on this particular kind of itch, so if your itching is from a different cause, this study might not be the right fit for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Do you experience itching after a skin prick test?
Can you commit to study visits and follow-ups?
Are you able to understand and agree to the study requirements?

Answer every question to see your result.

What does participation involve?

If you decide to take part in the IJAMP-Trial, you would be monitored closely for the effects of the treatment. This will likely involve a series of visits to the study clinic, where you might have check-ups and assessments by the medical team. You would receive a specific treatment, though the exact details of what that involves would be fully explained to you before you agree to participate. The study team will need to keep track of any changes you experience and how you feel. The total duration of your involvement in the study would be confirmed during your initial discussions with the research team.

Potential risks and benefits

Participating in research always comes with potential benefits and risks. The potential benefit of this study is that you might find relief from the itch caused by skin prick tests. Your involvement will also help researchers learn more about treating this condition, which could benefit others in the future. As with any treatment, there's always a chance of side effects, which the study team will explain in detail. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

—
Unverified
Austria

Common questions

What is a skin prick test?

A skin prick test is a common way to check for allergies. A tiny amount of something you might be allergic to is placed on your skin, and then the skin is gently pricked. Doctors check if a red, itchy bump appears, which can mean you have an allergy.

Why is this study called 'Phase IV'?

Phase IV means the treatment has already been tested for safety in earlier studies. Now, researchers want to see how well it works and if there are any long-term effects in a bigger group of people, often in real-world settings.

Do I have to be male or female to join?

No, this study is open to all adults, regardless of whether you are male, female, or another gender.

Will I get paid to join the study?

The study information doesn't mention payment. If you're interested, you should ask the study team about any potential reimbursement for travel or time.

What if I change my mind after joining?

You are always free to leave the study at any point, for any reason, without it affecting your future medical care.